Form 8-K - Current report:
SEC Accession No. 0001477932-25-000328
Filing Date
2025-01-17
Accepted
2025-01-17 16:05:19
Documents
15
Period of Report
2025-01-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nbio_8k.htm   iXBRL 8-K 22449
  Complete submission text file 0001477932-25-000328.txt   139539

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nbio-20250110.xsd EX-101.SCH 5874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20250110_lab.xml EX-101.LAB 13717
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20250110_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20250110_pre.xml EX-101.PRE 8614
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20250110_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT nbio_8k_htm.xml XML 3664
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-55299 | Film No.: 25538682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)